Abstract

SUMMARY:This report was based on data from the ESRD (End‐Stage Renal Disease) Registry Committee of the Korean Society of Nephrology and accounts for 60% of all patients on renal replacement therapy (RRT) in Korea. The data are from 31 December 1996. There were 208 centres providing dialysis (4.76 centres per million population [p.m.p.]) and 36 renal transplant centres. There were 18 161 (391.1 p.m.p.) patients on RRT of which 53% were on haemodialysis (HD), 16.4% on peritoneal dialysis (PD) and 30.6% with functioning renal transplants (TX). There was a 14% increase in the number of patients over the previous year (HD 12.3%, PD 8.5%, TX 20.4%). The incidence of treated ESRD was 5058 (108.9 p.m.p.). The mean age of existing patients was 48.3 years (HD, 48.4; PD, 50.2; KT, 37.5) and sex ratio was M:F 57:43 (HD, 55:45; PD, 54:46; KT, 67:33). The primary renal diseases were glomerulonephritis (21.6%), diabetic nephropathy (30.8%), hypertension (18.3%) and others (34.2%). Sixty‐five per cent of patients on HD and 35% on PD were treated with erythropoietin. Eleven per cent of patients on RRT (HD 11.4%, PD 8%) were serologically positive for hepatitis B infection and another 10% (HD 10.3%, PD 3.3%) were positive for hepatitis C infection. The rate of peritonitis was 0.78 episodes per patient year. There were 941 renal transplants in 1996 and the annual transplantation rate was 20.3 p.m.p. Eighty‐eight per cent of transplants were from live donors (65.5% living‐related and 34.5% living‐unrelated) and the other 12% were from cadaveric donors. The causes of death were cardiac (31.6%), vascular (24.5%), infection (19.4%), liver disease (3.1%), social (8.2%), miscellaneous (6.1%) and uncertain (7.1%). The annual mortality rate of RRT patients was 8.9% according to the report from Korean National Statistical Office.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.